CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses

Vaccine

Volumn 28, Issue 51, 2010, Pages 8183-8188

  Neves, Patrícia C C ^a   Rudersdorf, Richard A ^b   Galler, Ricardo ^a   Bonaldo, Myrna C ^a   Santana, Marlon Gilsepp Veloso de ^a   Mudd, Philip A ^b   Martins, Maurício A ^b   Rakasz, Eva G ^b   Wilson, Nancy A ^b   Watkins, David I ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

IFN ; Rhesus model; Yellow fever vaccine

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 4; NEF PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIF PROTEIN; YELLOW FEVER VACCINE;

ADENOVIRUS 5; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA DELTA T CELL RECEPTOR+ T LYMPHOCYTE; MACACA; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; INTERFERON-GAMMA; MACACA MULATTA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; YELLOW FEVER VACCINE;

EID: 78649680321     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.090     Document Type: Article

References (22)

1. WHO. Assessment of yellow fever epidemic risk- a decision- making tool for preventive imunization campaigns. Weekly epidemiological record 2007; 18(82):153-160.
2. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10(1):116-125.
3. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 205(13):3119-3131.
4. Barba-Spaeth G., Longman R.S., Albert M.L., Rice C.M. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 2005, 202(9):1179-1184.
5. Querec T., Bennouna S., Alkan S., Laouar Y., Gorden K., Flavell R., et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006, 203(2):413-424.
6. Martins M.A., Silva M.L., Eloi-Santos S.M., Ribeiro J.G., Peruhype-Magalhaes V., Marciano A.P., et al. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. Vaccine 2008, 26(9):1173-1184.
7. Neves P.C., Matos D.C., Marcovistz R.R., Galler T.L.R expression and NK cell activation after human yellow fever vaccination. Vaccine 2009, 27(41):5543-5549.
8. Martins M.A., Silva M.L., Marciano A.P., Peruhype-Magalhaes V., Eloi-Santos S.M., Ribeiro G.L., et al. Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?. Clin Exp Immunol 2007, 148(1):90-100.
9. Santos A.P., Matos D.C., Bertho A.L., Mendonca S.C., Marcovistz R. Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. Cytokine 2008, 42(2):152-155.
10. Bonaldo M.C., Martins M.A., Rudersdorf R., Mudd P.A., Sacha J.B., Piaskowski S.M., et al. Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques. J Virol 2010, 84(7):3699-3706.
11. Bonaldo M.C., Mello S.M., Trindade G.F., Rangel A.A., Duarte A.S., Oliveira P.J., et al. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol J 2007, 4:115.
12. Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 2009, 9(10):741-747.
13. Billiau A., Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 2009, 20(2):97-113.
14. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008, 28(5):710-722.
15. Schlesinger J.J., Foltzer M., Chapman S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 1993, 192(1):132-141.
16. Schlesinger J.J., Chapman S. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis. J Gen Virol 1995, 76(1):217-220.
17. + T cell lineage differentiation. Immunity 2009, 30(5):646-655.
18. Devilder M.C., Allain S., Dousset C., Bonneville M., Scotet E. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. J Immunol 2009, 183(6):3625-3633.
19. Poccia F., Agrati C., Martini F., Capobianchi M.R., Wallace M., Malkovsky M. Antiviral reactivities of gamma-delta T cells. Microbes Infect 2005, 7(3):518-528.
20. Shrestha B., Wang T., Samuel M.A., Whitby K., Craft J., Fikrig E., et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 2006, 80(11):5338-5348.
21. Fang H., Welte T., Zheng X., Chang G.J., Holbrook M.R., Soong L., et al. Gamma-delta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol 2010, 59(June (1)):71-80.
22. Franco D., Li W., Qing F., Stoyanov C.T., Moran T., Rice C.M., Ho D.D. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. Vaccine 2010, 28(August (35)):5676-5685.